Caffeine (Oral Route, Parenteral Route)

3 imperatives to transform health care in America. You're invited to watch it live

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Caffeine (Oral Route, Parenteral Route)

Drug Information provided by: Micromedex

US Brand Names

  • Cafcit

Description

Caffeine belongs to the group of medicines called central nervous system (CNS) stimulants. It is used to help restore mental alertness when unusual tiredness or weakness or drowsiness occurs. Caffeine's use as an alertness aid should be only occasional. It is not intended to replace sleep and should not be used regularly for this purpose.

Caffeine is also used in combination with ergotamine (for treatment of migraine and cluster headaches) or with certain pain relievers, such as aspirin or aspirin and acetaminophen. When used in this way, caffeine may increase the effectiveness of the other medicines. Caffeine is sometimes used in combination with an antihistamine to overcome the drowsiness caused by the antihistamine.

Citrated caffeine is used to treat breathing problems in premature babies.

Caffeine may also be used for other conditions as determined by your doctor.

Caffeine is present in coffee, tea, soft drinks, cocoa, chocolate, and kola nuts.

Caffeine powder and tablets are available without a prescription; however, your health care professional may have special instructions on its proper use. Citrated caffeine and caffeine and sodium benzoate are to be administered only by or under the supervision of your doctor.

Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, caffeine is used in certain patients with the following medical conditions:

  • Postoperative infant apnea (breathing problems after surgery in young babies)
  • Psychiatric disorders requiring electroconvulsive or shock therapy (ECT)
Before Using
DR602089 Portions of this document last updated: Nov. 1, 2011

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger